Results 191 to 200 of about 115,048 (305)

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

Blastoid Mantle Cell Lymphoma in the Leukemic Phase: Resolving a Morphological Dilemma Through Flow Cytometry. [PDF]

Cureus
Kundu A, Giri S, Basu A.
europepmc   +1 more source

Eccrine Squamous Syringometaplasia Mimicking Acute Cutaneous GVHD in a Pediatric HSCT Recipient: Case Report and Brief Review of the Indexed Literature

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Eccrine squamous syringometaplasia (ESS) is an uncommon reactive alteration of eccrine ducts, most often reported in oncologic and transplant settings, where it may clinically mimic acute cutaneous graft‐versus‐host disease (GVHD). We describe a 3‐year‐old boy with chronic granulomatous disease who developed a diffuse erythematous eruption 6 ...
Benedetta Galli, Cecilia Catapano, Iacopo Ghini, Mariateresa Rossi, Marina Venturini, Valeria Boccaletti   +5 more
wiley   +1 more source

Richter-like transformation of CLL/SLL after a temporary hold of ibrutinib: A case report. [PDF]

Leuk Res Rep
Chiang TL, Frater J, Cashen A.
europepmc   +1 more source

A Rare Case of Cutaneous Extramedullary Hematopoiesis in Chronic Myeloid Leukemia

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Cutaneous extramedullary hematopoiesis (CEH) is a rare manifestation of extramedullary hematopoiesis (EMH), a process typically associated with fetal development or myeloproliferative neoplasms. EMH most commonly involves the spleen, liver, and lymph nodes, with CEH being exceedingly rare in chronic myeloid leukemia (CML).
Bennett Christie‐Nguyen, Hanadi El Achi, Levani Iashvili, Amer Wahed, Brenda Mai, Jacob Armstrong   +5 more
wiley   +1 more source

Leukemic penile ulcer as the presenting symptom of chronic lymphatic leukemia. [PDF]

J Surg Case Rep
Sandhu HS, Chandra S, Joshi S.
europepmc   +1 more source

Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis. [PDF]

Biomark Res
Angotzi F, Bevilacqua A, Serafin A, Danesin N, Cellini A, Leone G, D'Antiga M, Pagnin E, Frezzato F, Facco M, Piazza F, Trentin L, Visentin A.   +12 more
europepmc   +1 more source

HAT‐PCR is non‐inferior to NGS when quantifying measurable residual disease for myeloma

British Journal of Haematology, EarlyView.
Elizabeth Hughes, Piers Blombery, Sushmitha Kannan, Tiffany Khong, Andrew Spencer, Alexander Morley   +5 more
wiley   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Case Report: renal allograft infiltration by chronic lymphocytic leukemia successfully treated with zanubrutinib. [PDF]

Front Oncol
Abboud B, Rodriguez NG, Babar A, Coreas N, Robbins K, Kunwor R.   +5 more
europepmc   +1 more source